Author:
Norman Sarah M.,Sullivan Kelli M.,Liu Fang,DiPaula Bethany A.,Jose Pedro A.,Kitchen Christopher A.,Feldman Stephanie M.,Kelly Deanna L.
Funder
National Institutes of Health
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health
Reference38 articles.
1. Abi-Dargham A. Schizophrenia: overview and dopamine dysfunction. Journal of Clinical Psychiatry 2014;75:e31.
2. Kelly DL, McMahon RP, Liu F, Love RC, Wehring HJ, Shim JC, et al. Cardiovascular disease mortality in patients with chronic schizophrenia treated with clozapine: a retrospective cohort study. Journal of Clinical Psychiatry 2010;71(3):1–478.
3. Buchanan RW, Kreyenbuhl J, Kelly DL, Noel JM, Boggs DL, Fischer BA, et al. The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements. Schizophrenia Bulletin 2010;36:71–93.
4. Conley RR, Tamminga CA, Kelly DL, Richardson CM. Treatment-resistant schizophrenic patients respond to clozapine after olanzapine non-response. Biological Psychiatry 1999;46:73–77.
5. Wahlbeck K, Cheine M, Essali A, Adams C. Evidence of clozapine’s effectiveness in schizophrenia: a systematic review and meta-analysis of randomized trials. American Journal of Psychiatry 1999;156:990–99.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献